홈
Rx
LP

Luye Pharma Group

204
16
2
3.7(69)

회사 소개

  • 법인명: Luye Pharma Group
  • 국제 명칭: 绿叶制药集团 (Luye Pharma Group Ltd.), Yantai and Shanghai, China
  • 브랜드명 / 상호: Luye Pharma
  • 등록 국가: China
  • 주소: ShandongYantaiNo. 9, Baoyuan Road, Laishan District, Yantai City, Shandong Province • Shandong
설명:

Luye Pharma Group, established in 1994 in China and listed on the Hong Kong Stock Exchange, develops, produces, and markets innovative pharmaceutical products focused on oncology, cardiovascular disease, and alimentary tract/metabolism, with central nervous system disorders emerging as a growing focus area. The company pioneered China's first liposome industrialization breakthrough and developed proprietary continuous dynamic preparation technology for microspheres, leading internationally in long-acting microsphere treatments for neurodegenerative diseases, alongside internationally marketed Paclitaxel liposome formulations. Through acquisitions — including Nanjing Kanghai and Cisco Pharmaceutical (2007), the transdermal drug-delivery business of Swiss group Acino (2016), and rights to AstraZeneca's Seroquel and its slow-release tablets across 51 countries (2018) — Luye has expanded from its Yantai, Shandong origins into mainstream European and US markets, with production lines passing EU GMP inspection in 2013. Offering CRO services and backed by an experienced, internationally certified R&D team, the company distributes its rich portfolio of finished dosage forms, APIs, and bio products across Central/South America, Eastern Europe, Asia, the Middle East, North America, and Western Europe.

사업 활동

완제 의약품

제조업체

약물전달시스템

제조업체

바이오의약품

생명공학/바이오제약 기업대리점/대리인수출업체제조업체

ATC 분류체계 (해부치료화학분류)

제조업체대리점/대리인수출업체

원료의약품(API)

대리점/대리인제조업체수출업체

부형제 & 첨가제

수출업체대리점/대리인제조업체
판매 시장
주요 제품/서비스

당사 제품 & 서비스

Sell · ATC (Anatomical Therapeutic Chemical) Classification
Erzofri
필터:
정렬:

    댓글이 없습니다.